A Phase 3 Randomized Safety and Efficacy Trial of HP802-247 in the Treatment of Chronic Venous Leg Ulcers (EU).
Phase of Trial: Phase III
Latest Information Update: 05 Oct 2016
Price : $35 *
At a glance
- Drugs HP 802247 (Primary)
- Indications Varicose ulcer
- Focus Registrational; Therapeutic Use
- Sponsors Smith & Nephew
- 23 Feb 2015 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
- 19 Nov 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 30 Oct 2013 New source identified and integrated: ClinicalTrials.gov record.